This content is machine translated Diabetes treatment Additive glucose-lowering therapy for type 1 diabetics – weighing benefits and risks Overweight type 1 diabetics in whom insulin therapy alone is not sufficient for glycemic control may receive additional oral treatment with the SGLT2 inhibitor dapagliflozin or the dual SGLT1/SGLT2 inhibitor…
View Post 1 min This content is machine translated Online training Swiss Oncology in Motion Acute Myeloid Leukemia Module After many years without noticeable therapeutic progress, a number of new treatment options for acute myeloid leukemia have recently become available that could improve the situation for those affected. Prof.… CME-Test
View Post 11 min This content is machine translated Role of incretin-based therapy GLP-1-RA and DPP-4 inhibitors in the management of type 2 diabetes. Insulin secretion by pancreatic beta cells is primarily influenced by glucose levels in the portal vein. In addition, secretion is also modulated by the so-called incretins. After food intake, they…
View Post 3 min This content is machine translated GLP-1 receptor agonists in type 2 diabetes Nephroprotection with semaglutide and liraglutide – direct or indirect effects? In a post-hoc analysis of large randomized placebo-controlled trials, HbA1c and body weight and blood pressure were examined as mediator variables regarding the renal protective effects of the GLP-1 receptor…
View Post 3 min This content is machine translated Diabetic ketoacidosis Study: ketoacidosis in infancy affects brain development Diabetic ketoacidosis (DKA) can have consequences for a child’s brain, an American research group shows in the journal Diabetes Care. The German Diabetes Society (DDG) points out the need to…
View Post 1 min This content is machine translated T2DM X-CHANGE 2020 The Kidney as a Window to the Heart – Holistic Treatment of Type 2 Diabetes It has long been known that type 2 diabetes not only increases the risk of cardiovascular disease, but is also one of the main causes of kidney disease. What consequences…
View Post 5 min This content is machine translated Corona pandemic Current data on COVID-19 and diabetes In particular, older diabetics with a high BMI have an increased risk of a severe course and mortality rates are also higher compared to the general population. The interactions involved…
View Post 4 min This content is machine translated SGLT-2 inhibitors Dapagliflozin now also available for non-diabetics for the treatment of heart failure (HFrEF) Based on the results of the DAPA-HF study, Swissmedic has approved dapagliflozin for the treatment of heart failure with reduced ejection fraction (HFrEF), whether or not patients have type 2…
View Post 3 min This content is machine translated Diabetes Cases Type 2 diabetes mellitus with incipient kidney damage A 58-year-old preadipose patient with type 2 diabetes mellitus and other comorbidities is diagnosed with incipient renal impairment during a workup. This makes it necessary to adjust the diabetes therapy.
View Post 3 min This content is machine translated Rheumatoid arthritis Using “windows of opportunity” for disease-modifying therapy. Diagnosis at an early stage of the disease is a prerequisite to take advantage of the time window for optimally effective disease-modifying therapy (DMARD). This not only enables a reduction…
View Post 2 min This content is machine translated SGLT2 inhibitor convinces Dapagliflozin may score well in nephro- and cardioprotection Patients with diabetic nephropathy can now be effectively treated with SGLT2 inhibitors. They are also said to have cardioprotective effects. Dapagliflozin is now the first and only antidiabetic agent approved…
